Pro (With Caution): Extended oncologic indications in liver transplantation.

Area of Science:

• Hepatobiliary Surgery
• Transplant Oncology
• Surgical Oncology

Background:

• Liver transplantation (LT) is effective for treating specific cancers like hepatocellular carcinoma and neuroendocrine tumors.
• Current consensus is lacking regarding expanded LT indications for other cancers such as cholangiocarcinoma and colorectal metastases.

Purpose of the Study:

• To evaluate the potential for expanding indications for liver transplantation in cancer treatment.
• To identify key factors for prospective investigations into expanded LT criteria for oncologic indications.

Main Methods:

• Review of current practices and literature regarding LT for cancer.
• Discussion of necessary components for future research, including staging, patient selection, and donor criteria.

Main Results:

• While established criteria for LT in cancer are effective, consensus on expanding these criteria is not yet reached.
• Arguments for moderately loosened LT criteria in cancer treatment are gaining validity.
• Transplant oncology is poised for significant growth due to improved management of comorbidities and transplant-related mortality.

Conclusions:

• Expanded cancer indications for LT necessitate cautious exploration and rigorous prospective studies.
• Future research should focus on precise cancer staging, tumor biology, patient selection, and donor criteria.
• Liver transplantation is increasingly recognized as a vital tool in surgical oncology.